Medartis Holding AG (SIX: MED.SW) Stock Competitors & Peer Comparison
See MED.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MED.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MED.SW | CHF 91.70 | +1.78% | 1.1B | 76.42 | CHF 1.20 | N/A |
| ABT.SW | CHF 72.50 | -2.68% | 125.5B | 19.79 | CHF 3.66 | +2.78% |
| SOON.SW | CHF 281.00 | +1.52% | 16.7B | 30.88 | CHF 9.10 | +1.70% |
| ZBH.SW | CHF 75.00 | -3.23% | 14.5B | 12.13 | CHF 6.19 | +1.04% |
| KURN.SW | CHF 20.36 | +4.73% | 807.7M | 112.49 | CHF 0.18 | N/A |
| METN.SW | CHF 838.00 | -1.64% | 375.4M | -34.83 | -CHF 24.06 | N/A |
| SHLTN.SW | CHF 1.07 | +0.00% | 39.7M | -0.62 | -CHF 1.71 | N/A |
Stock Comparison
Abbott Laboratories (SIX: ABT.SW)
MED.SW vs ABT.SW Comparison October 2026
Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MED.SW stands at 1.1B. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, MED.SW is priced at CHF 91.70 on the SIX, while ABT.SW trades at CHF 72.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MED.SW currently has a P/E ratio of 76.42, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, MED.SW's ROE is +0.05%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, MED.SW is more volatile compared to ABT.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check ABT.SW's competition here